Chemo and Immunotherapy in Non-EGFR Lung Cancer
In recent years, the landscape of non-small cell lung cancer (NSCLC) treatment has undergone a significant transformation, driven primarily by ...
In recent years, the landscape of non-small cell lung cancer (NSCLC) treatment has undergone a significant transformation, driven primarily by ...
In an innovative breakthrough study published in BMC Cancer, researchers have unveiled that systemic inflammation biomarkers may hold the key ...
In a groundbreaking development in the fight against non-small cell lung cancer (NSCLC), researchers have unveiled promising results from a ...
In the relentless battle against non-small cell lung cancer (NSCLC), radiotherapy (RT) stands as a indispensable weapon. However, like many ...
The research surrounding perioperative oncology has taken a significant leap forward, particularly in the context of non-small cell lung cancer ...
In an illuminating correction to a groundbreaking study published recently in BMC Cancer, researchers have revisited the outcomes of primary ...
In a groundbreaking advancement that could reshape the therapeutic landscape for advanced non-small cell lung cancer (NSCLC), researchers have identified ...
In the evolving landscape of cancer therapeutics, immunotherapy has reshaped the treatment paradigm for various malignancies, notably non-small cell lung ...
In a groundbreaking new study published in Cell Death Discovery, scientists have unveiled the remarkable capacity of panobinostat to amplify ...
A groundbreaking editorial recently published in the latest volume of Oncoscience sheds new light on the complex relationship between immune ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine